MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 08-09-2022
Epizyme Current Ratio 2011-2025 | EPZM
Annual Current Ratio Epizyme
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 9.33 | 11.6 | 7.2 | 11.6 | 11.5 | 11.5 | 11.4 | 4.62 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.6 | 4.62 | 9.86 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M |  USA |
 |
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
3.76 | $ 4.79 | 2.57 % | $ 795 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
3.4 | $ 3.39 | 1.02 % | $ 262 M | USA |
 |
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | USA |
 |
Ascendis Pharma A/S
ASND
|
0.918 | $ 213.61 | 1.64 % | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M |  Israel |
 |
Aptorum Group Limited
APM
|
3.71 | $ 1.32 | -0.75 % | $ 7.2 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.39 | -0.88 % | $ 8.16 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
AstraZeneca PLC
AZN
|
1.65 | $ 89.7 | -0.64 % | $ 96.9 B | Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
1.87 | $ 25.67 | -0.87 % | $ 1.24 B | USA |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 9.55 | 0.63 % | $ 140 M | USA |
 |
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
2.29 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.33 | 2.19 % | $ 14.6 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | USA |
 |
Baudax Bio
BXRX
|
0.293 | - | 0.59 % | $ 63 K | USA |
 |
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
3.08 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
2.08 | $ 573.02 | -1.38 % | $ 43.4 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
6.16 | - | -16.75 % | $ 25.8 M | USA |
 |
Clovis Oncology
CLVS
|
0.629 | - | -7.23 % | $ 13 M | USA |
 |
Biogen
BIIB
|
2.47 | $ 174.8 | 1.33 % | $ 25.5 B | USA |
 |
BioVie
BIVI
|
8.46 | $ 1.52 | 0.33 % | $ 2.25 M | USA |
 |
Cortexyme
CRTX
|
2.03 | - | -1.05 % | $ 67.1 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.86 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.612 | $ 11.54 | 0.87 % | $ 746 M | USA |
 |
Benitec Biopharma
BNTC
|
43.4 | $ 12.57 | -3.01 % | $ 517 M | USA |
 |
BioNTech SE
BNTX
|
7.22 | $ 95.76 | -0.25 % | $ 27.2 B |  Germany |
 |
Eloxx Pharmaceuticals
ELOX
|
0.665 | - | -5.68 % | $ 8.28 M | USA |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 0.29 | -1.45 % | $ 631 M | Israel |
 |
Catalyst Biosciences
CBIO
|
3.06 | $ 15.4 | 0.59 % | $ 1.01 B | USA |
 |
Enochian Biosciences
ENOB
|
0.278 | - | - | $ 40.5 M | USA |
 |
Cerus Corporation
CERS
|
1.4 | $ 2.22 | 3.02 % | $ 410 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Burford Capital Limited
BUR
|
2.14 | $ 9.24 | 1.04 % | $ 1.52 B | Britain |